The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors

1965 ◽  
Vol 163 (990) ◽  
pp. 1-44 ◽  
Keyword(s):  
Smooth Muscle ◽  
Binding Site ◽  
Equilibrium Constant ◽  
Rate Constant ◽  
Binding Sites ◽  
Acetylcholine Receptors ◽  
Kinetic Properties ◽  
Kinetic Behaviour ◽  
Kinetics Of ◽  
Bound Drug

In an attempt to study the properties of acetylcholine receptors in intestinal smooth muscle, measurements have been made of the uptake of tritium-labelled atropine and methylatropinium, and of 14 C-labelled methylfurmethide by the longitudinal muscle of guinea-pig small intestine in vitro . Substantial amounts of atropine were taken up from very dilute solutions, a clearance of 160 ml. per g tissue (wet weight) being achieved at the lowest concentration tested (1.5 × 10 -10 M). Analysis of the curve relating atropine uptake at equilibrium to the bath concentration, which was explored over a concentration range 1.5 × 10 -10 M to 2.5 × 10 -3 M, enabled three components to be distinguished: (1) A binding site with a capacity of 180 pmoles/g, and equilibrium constant 1.1 × 10 -9 M. (2) A binding site of capacity about 1000 pmoles/g and equilibrium constant about 5 × 10 -7 M. (3) A compartment with a clearance of 4.7 ml./g (nonsaturable). The equilibrium constant of the first binding site agreed exactly with that measured for acetylcholine antagonism in the same tissue. Methylatropinium was taken up in rather smaller amounts than atropine, and analysis of the uptake curve showed a binding site of capacity about 90 pmoles/g with an equilibrium constant 6.5 × 10 -10 M, an ill-defined series of binding sites with much higher equilibrium constants, and a constant clearance of about 0.4 ml. /g. Analysis of this curve was much less clear cut than that of atropine. The equilibrium constant for blockade of acetylcholine receptors by methylatropinium was 4.7 × 10 -10 M. Atropine was not taken up appreciably by striated muscle, nerve or tendon of the guineapig; hydrolysed atropine was not taken up by smooth muscle (and lacks atropinic activity); cocaine and d -tubocurarine in high concentrations did not affect atropine uptake; lachesine and benzhexol blocked atropine uptake competitively at low concentrations, and with lachesine the equilibrium constant for this interaction agreed with that measured for acetylcholine antagonism (1.4 × 10 -9 M). These findings suggested that the atropine taken up could be related to receptor-bound drug. The kinetics of atropine uptake and washout were studied over the concentration range 0.5-5 × 10 -9 M. Uptake and washout took place approximately exponentially between 2½ and 50 min, and the rate constant was 4.5-5 × 10 -4 s -1 for both uptake and washout. The uptake rate constant did not increase with concentration. This contrasted with the kinetics of receptor blockade, which took place much faster, with a rate constant which increased linearly with concentration, in accordance with the theoretical kinetic behaviour of a single binding site. This finding precluded a simple identification of atropine taken up with receptor-bound drug. Studies with various metabolic inhibitors suggested that no metabolic energy was required for the accumulation of atropine, and by dialysis experiments, the atropine taken up was shown to be bound in homogenized tissue. A theoretical study, using an analogue computer, was made of the kinetic properties of three passive binding systems, in order to see whether the observed kinetic behaviour could be simulated. It was found that a system of four binding sites in series, with only one communicating directly with the surrounding medium, could show these kinetic properties, and the outermost binding site could still show the kinetic behaviour of receptors. Experimental testing of this model demands more accurate kinetic measurements than can be made by the method used in this study. The acetylcholine-like stimulant, methylfurmethide, was taken up very slowly (taking more than 24 h to reach equilibrium), reaching a clearance of about 5 ml. /g after 6 h. This uptake was unaffected by atropine in a concentration sufficient to block 80% of acetylcholine receptors, but was blocked by depolarization in high potassium solution, suggesting that it was behaving passively as a slowly permeant cation. No uptake referable to acetylcholine receptors was detected. These findings are discussed in relation to the abundance and chemical behaviour of acetylcholine receptors in smooth muscle, and in relation to current theories of drug action.

Kinetics of Na+/H+ exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester

1995 ◽  
Vol 268 (1) ◽  
pp. C14-C20 ◽  
Author(s):  
G. Hoffmann ◽  
Y. Ko ◽  
A. Sachinidis ◽  
B. O. Gobel ◽  
H. Vetter ◽  
...  
Keyword(s):  
Smooth Muscle ◽  
Vascular Smooth Muscle ◽  
Smooth Muscle Cells ◽  
Vascular Smooth Muscle Cells ◽  
Muscle Cells ◽  
Maximal Activity ◽  
Hill Coefficient ◽  
Kinetic Properties ◽  
Wistar Kyoto ◽  
Kinetics Of

The kinetic properties of Na+/H+ exchange were investigated in vascular smooth muscle cells (VSMC) in culture from normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR). Antiport activity was measured in 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein-loaded cells after nigericin-induced cytosolic acidification. Studies were performed without (control) and with pretreatment of the cells with phorbol 12-myristate 13-acetate (PMA; 200 nM). Na+/H+ exchange markedly differed between the two strains with lower Hill coefficients [1.56 +/- 0.17 (SE) vs. 2.62 +/- 0.36] and higher maximal activity (Vmax) values (55.85 +/- 5.24 vs. 31.11 +/- 2.38 mmol H+.l-1.min-1) in SHR compared with WKY cell lines. PMA markedly altered the antiport kinetics in WKY VSMC with a decrease in the Hill coefficient (1.75 +/- 0.14) without affecting Vmax (31.88 +/- 1.55 mmol H+.l-1.min-1). In VSMC from SHR, PMA had no effect on the kinetic variables investigated. Thus two kinetic abnormalities are present with respect to Na+/H+ antiport activity in VSMC from SHR compared with WKY, i.e., increased Vmax and decreased Hill coefficient. The observation that PMA does not affect the kinetics of the Na+/H+ antiport in VSMC from SHR suggests a marked degree of antiporter prestimulation in this animal model of genetic hypertension.

scholarly journals Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change

1992 ◽  
Vol 285 (2) ◽  
pp. 419-425 ◽  
Author(s):  
U Christensen ◽  
L Mølgaard
Keyword(s):  
Ligand Binding ◽  
Binding Site ◽  
Conformational Change ◽  
Conformational Changes ◽  
Binding Sites ◽  
High Specificity ◽  
Stopped Flow ◽  
Protein Fluorescence ◽  
Lysine Residues ◽  
Kinetics Of

The kinetics of a series of Glu-plasminogen ligand-binding processes were investigated at pH 7.8 and 25 degrees C (in 0.1 M-NaCl). The ligands include compounds analogous to C-terminal lysine residues and to normal lysine residues. Changes of the Glu-plasminogen protein fluorescence were measured in a stopped-flow instrument as a function of time after rapid mixing of Glu-plasminogen and ligand at various concentrations. Large positive fluorescence changes (approximately 10%) accompany the ligand-induced conformational changes of Glu-plasminogen resulting from binding at weak lysine-binding sites. Detailed studies of the concentration-dependencies of the equilibrium signals and the rate constants of the process induced by various ligands showed the conformational change to involve two sites in a concerted positive co-operative process with three steps: (i) binding of a ligand at a very weak lysine-binding site that preferentially, but not exclusively, binds C-terminal-type lysine ligands, (ii) the rate-determining actual-conformational-change step and (iii) binding of one more lysine ligand at a second weak lysine-binding site that then binds the ligand more tightly. Further, totally independent initial small negative fluorescence changes (approximately 2-4%) corresponding to binding at the strong lysine-binding site of kringle 1 [Sottrup-Jensen, Claeys, Zajdel, Petersen & Magnusson (1978) Prog. Chem. Fibrinolysis Thrombolysis 3, 191-209] were observed for the C-terminal-type ligands. The finding that the conformational change in Glu-plasminogen involves two weak lysine-binding sites indicates that the effect cannot be assigned to any single kringle and that the problem of whether kringle 4 or kringle 5 is responsible for the process resolves itself. Probably kringle 4 and 5 are both participating. The involvement of two lysine binding-sites further makes the high specificity of Glu-plasminogen effectors more conceivable.

The kinetics of action of acetylcholine antagonists in smooth muscle

1966 ◽  
Vol 164 (996) ◽  
pp. 488-510 ◽  
Keyword(s):  
Smooth Muscle ◽  
Binding Capacity ◽  
Equilibrium Constants ◽  
Dose Effect ◽  
Analogue Computer ◽  
Kinetic Properties ◽  
Receptor Complexes ◽  
Rate Limiting Step ◽  
Drug Receptor ◽  
Kinetics Of

The rate-limiting step in recovery of acetylcholine sensitivity in smooth muscle after exposure to atropine or hyoscine could be the dissociation of drug-receptor complexes (dissociationlim ited model) or diffusion of drug away from the neighbourhood of the receptors (biophase model). These two models differ in the details of the predicted kinetics of development and decline of antagonism. Their theoretical kinetic properties have been worked out mathematically with the aid of an analogue computer, and com pared with experimental measurements made in guinea-pigileum longitudinal muscle preparations. The kinetic properties of antagonists applied singly could be explained either by the dissociation-limited model, or by the biophase model, provided that the size of the biophase bore a certain relation to the binding capacity of the receptors. In studies of the interaction of fastand slow-acting antagonists, it was found that the dissociation-limited model could alone account for the observed effects. It was concluded that the kinetics of action of hyoscine and atropine reflected their rate of reaction with receptors, an d that measurements of antagonist kinetics were a valid guide to drug-receptor rate constants. A consequence of the dissociation-limited model, that persistent antagonists should fail to show the classical parallel shift of log-dose effect curves when tested against agonists of low efficacy, was borne out experimentally, and this effect was used to estimate indirectly the equilibrium constants of alkyltrimethylammonium salts.

Kinetics of response to epinephrine of isolated rabbit ear

1960 ◽  
Vol 199 (4) ◽  
pp. 710-714 ◽  
Author(s):  
R. H. Stinson ◽  
A. C. Burton
Keyword(s):  
Smooth Muscle ◽  
Equilibrium Constant ◽  
Negative Correlation ◽  
Muscle Tension ◽  
Receptor Complex ◽  
Constant Flow ◽  
Rabbit Ear ◽  
Reversible Formation ◽  
Drug Receptor ◽  
Kinetics Of

A theory for the response of the isolated rabbit ear to various concentrations of catecholamines, based on the reversible formation of a drug-receptor complex, is presented. For application of such a theory the response measured must be primary. The response measured is the increase in driving pressure required to maintain a constant flow of perfusate when a pressor drug is added. This, with a slight correction, is proportional to vascular smooth muscle tension. The agreement between results (50 curves) and theory is very good. For the reaction the over-all equilibrium constant, K, is 8.19 x 106 (S.E.M. = 1.28 x 106), ΔF° = –9.4 Kcal and, from the change in K with temperature, ΔH = 14.5 Kcal; values within the normal biological range. A negative correlation between K and the maximum response of the preparations suggests that the reaction may consist of two, or more, steps. The equilibrium constant for the first step, i.e. formation of the complex, can be roughly estimated as 15.8 x 106.

INTERACTION OF PLASMIN WITH ALPHA-2 MACROGLOBULIN (α2 M): EFFECT OF ANTIFIBRINOLYTIC AGENTS

1987 ◽  
Author(s):  
J Steiner ◽  
D Strickland
Keyword(s):  
Rate Constant ◽  
Conformational Changes ◽  
Binding Sites ◽  
Second Order ◽  
Kinetic Constants ◽  
Association Rate ◽  
Antifibrinolytic Agents ◽  
Nonspecific Proteolysis ◽  
Kinetics Of ◽  
Plasmin Inhibitor

Harpel (Harpel, P.C. (1981) J. Clin. Invest 68, 46-55) reported that levels of α2M-plasmin complexes are elevated in patients receiving urokinase. He found that the distribution of plasmin between the two inhibitors, α2M and α2-plasmin inhibitor (α2PI) is dependent upon whether plasmin is added directly to plasma, or whether plasminogen in plasma is activated to plasmin by urokinase. In order to investigate possible mechanisms regulating the distribution of plasmin between these two inhibitors, a study was initiated to examine the effects of antifibrinolytic agents on the reaction of plasmin with α2M. The kinetics of the reaction were measured by monitoring conformational changes in the inhibitor resulting from exomplex formation. In order to minimize nonspecific proteolysis of the inhibitor by plasmin, the reaction was performed under conditions where the concentration of α2M was greater than that of the enzyme. The reaction between Lys77-plasmin and α2M followed second order kinetics with a rate constant of 1.8 X 105M-1 s-1. This rate was not affected 1 mM EACA or by 10 uM histidine rich glycoprotein (HRG). Further, it was found that the rate of Val442-plasmin was essentially the same as that found for Lys77-plasmin. Therefore, the binding of these ligands to the lysine binding sites of plasmin do not affect the association rate between plasmin and α2M. This is in contrast to the reaction of plasmin with α2-PI, where the binding of ligands to the lysine binding sites of plasmin reduce the rate of the reaction (Petersen & Clerrmensen (1981) Biochem. J. 199, 121-127). The kinetic constants measured predict that under conditions when the lysine binding sites of plasmin are occupied, α2M will effectively compete with α2PI in inhibiting plasmin. Further, these studies inplicate HRG as a molecule capable of regulating the distribution of plasmin between these two inhibitors.

The Kinetics of Activated Thrombin-Activatable Fibrinolysis Inhibitor with Respect to Plasminogen Binding Site Removal From Fibrin Degradation Products.

Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 3185-3185
Author(s):  
Jonathan H. Foley ◽  
Michael E. Nesheim
Keyword(s):  
Binding Site ◽  
Binding Sites ◽  
Degradation Products ◽  
Catalytic Efficiency ◽  
Plasminogen Activation ◽  
Thrombin Activatable Fibrinolysis Inhibitor ◽  
Fibrin Degradation Products ◽  
Fibrinolysis Inhibitor ◽  
Arginine Residues ◽  
Kinetics Of

Abstract Abstract 3185 Poster Board III-122 TAFI (thrombin activatable fibrinolysis inhibitor, or carboxypeptidase U) is a plasma zymogen that can be activated by thrombin, thrombin-thrombomodulin or plasmin. When activated, TAFIa cleaves C-terminal lysine and arginine residues from plasmin modified fibrin (Fn'). Fn' as a cofactor increases the rate of plasminogen activation by 3-fold over intact fibrin and 3000-fold compared to in the absence of fibrin. Upon extensive treatment with TAFIa, the cofactor activity of TAFIa modified fibrin decreases by approximately 97%. Determining the kinetics of TAFIa will give insight into how much TAFIa is required to efficiently inhibit plasminogen activation and fibrinolysis. The kinetics of TAFIa on its primary physiological substrate were measured by exploiting the binding of plasminogen to fibrin degradation products (FDPs). Fluorescently labeled plasminogen (5IAF-Pg) was equilibrated with FDPs labeled with a quencher, QSY C5-maleimide (QSY-FDP). When 5IAF-Pg is bound to QSY-FDP a baseline fluorescence reading is obtained. When treated with TAFIa, plasminogen binding sites are removed from the QSY-FDP and the fluorescence increases. A model was used to convert the rate of fluorescence increase into the rate of Plasminogen binding site removal. The model includes two distinct binding sites on QSY-FDPs (C-terminal and internal lysines), only one of which is susceptible to removal by TAFIa (C-terminal lysine). 5IAF-Glu-Pg (fluorescent native plasminogen) binds to QSY-FDP with a Kd of 176nM and when QSY-FDP are treated with TAFIa the Kd increases to 1.06μM. It appears that 5IAF-Glu-Pg has the ability to weakly bind TAFIa-treated QSY-FDP, however, the capacity is greatly reduced. Similar binding constants were obtained for 5IAF-Lys-Pg (fluorescent plasmin-cleaved plasminogen) (Kd=92nM; Kd (+TAFIa)=1.55μM). The increase in Kd upon treatment of the QSY-FDP with TAFIa is similar to that observed with 5IAF-Glu-Pg, however, the capacity of the FDPs to bind 5IAF-Lys-Pg is relatively unchanged. The calculated rate of 5IAF-Glu-Pg binding site removal by TAFIa was determined at various QSY-FDP concentrations (0-2 μM). The data are hyperbolic in nature and when fit using the Michaelis-Menten model the kcat and Km of plasminogen binding site removal were 2.34 s-1 and 142.6nM, respectively, implying a catalytic efficiency of 16.41 μM-1s-1. The rate is sensitive to the TAFIa concentration with all TAFIa concentrations (50, 75 and 100pM) yielding similar kinetic parameters. The data described here suggest that TAFIa is very efficient in removing plasminogen binding sites. The catalytic efficiency of TAFIa toward QSY-FDP is 60-fold higher than reported for bradykinin, which was previously the best known substrate of TAFIa. This increased catalytic efficiency is due to a much lower Km (0.146 μM compared to 70.6 μM). These data are reflective of plasminogen site removal and not every C-terminal lysine or arginine cleaved by TAFIa is expected to be involved in plasminogen binding. Therefore, the catalytic efficiency of TAFIa reported here (16.41 μM-1s-1) is likely a lower limit for the true value. Disclosures No relevant conflicts of interest to declare.

scholarly journals Alignment of caldesmon on the actin-tropomyosin filaments

1995 ◽  
Vol 309 (3) ◽  
pp. 951-957 ◽  
Author(s):  
T S Tsuruda ◽  
M H Watson ◽  
D B Foster ◽  
J J J C Lin ◽  
A S Mak
Keyword(s):  
Escherichia Coli ◽  
Smooth Muscle ◽  
Binding Site ◽  
Actin Filament ◽  
Binding Sites ◽  
Human Fibroblast ◽  
Thin Filament ◽  
Terminal Region ◽  
Terminal Domain ◽  
Terminal Fragment

We have reported previously that each smooth-muscle caldesmon binds predominantly to a region within residues 142-227 of tropomyosin, but a weaker binding site also exists at the N-terminal region of tropomyosin [Watson, Kuhn, Novy, Lin and Mak (1990) J. Biol. Chem. 265, 18860-18866]. In view of recent evidence for the presence of tropomyosin-binding sites at both the N- and C-terminal domains of caldesmon, we have studied the binding of the N- and C-terminal fragments of human fibroblast caldesmon expressed in Escherichia coli to tropomyosin and its CNBr fragments. The N-terminal fragment, CaD40 (residues 1-152), binds tropomyosin, but the interaction is mostly abolished in the presence of actin. CaD40 binds strongly to Cn1B(142-281) of tropomyosin, but weakly to Cn1A(11-127). The C-terminal fragment, CaD39, which corresponds to residues 443-736 of gizzard caldesmon, binds tropomyosin, and the interaction is enhanced by actin. CaD39 binds to both Cn1A(11-127) and Cn1B(142-281) of tropomyosin. Our results suggest that the N-terminal domain of caldesmon interacts with the C-terminal half of one tropomyosin molecule, whereas the C-terminal domain binds to both N- and C-terminal regions of the adjacent tropomyosin molecule along the actin filament. In addition, the binding of the N-terminal domain of caldesmon to the actin-tropomyosin filament is weak, which may allow this domain to project off the thin filament to interact with myosin.

scholarly journals The combination of carbon monoxide–haem with apoperoxidase

1969 ◽  
Vol 114 (4) ◽  
pp. 719-724 ◽  
Author(s):  
Charles Phelps ◽  
Eraldo Antonini
Keyword(s):  
Activation Energy ◽  
Carbon Monoxide ◽  
Rate Constant ◽  
Binding Sites ◽  
Order Process ◽  
First Order ◽  
Effects Of Ph ◽  
Kinetics Of

1. Static titrations reveal an exact stoicheiometry between various haem derivatives and apoperoxidase prepared from one isoenzyme of the horseradish enzyme. 2. Carbon monoxide–protohaem reacts rapidly with apoperoxidase and the kinetics can be accounted for by a mechanism already applied to the reaction of carbon monoxide–haem derivatives with apomyoglobin and apohaemoglobin. 3. According to this mechanism a complex is formed first whose combination and dissociation velocity constants are 5×108m−1sec.−1 and 103sec.−1 at pH9·1 and 20°. The complex is converted into carbon monoxide–haemoprotein in a first-order process with a rate constant of 235sec.−1 for peroxidase and 364sec.−1 for myoglobin at pH9·1 and 20°. 4. The effects of pH and temperature were examined. The activation energy for the process of complex-isomerization is about 13kcal./mole. 5. The similarity in the kinetics of the reactions of carbon monoxide–haem with apoperoxidase and with apomyoglobin suggests structural similarities at the haem-binding sites of the two proteins.

Kinetics of the reaction H + C2H6 → H2 + C2H5 in the temperature region of 1000 K

1984 ◽  
Vol 62 (1) ◽  
pp. 86-91 ◽  
Author(s):  
J.-R. Cao ◽  
M. H. Back
Keyword(s):  
Equilibrium Constant ◽  
Rate Constant ◽  
Temperature Region ◽  
Recent Measurement ◽  
Hydrogen Atoms ◽  
Elementary Reactions ◽  
Temperature Range ◽  
Hydrogen Molecules ◽  
Kinetics Of ◽  
Rate Controlling Step

A system for the measurement of rate constants for elementary reactions of hydrogen atoms in the temperature region of 1000 K is described. The concentration of hydrogen atoms is controlled by the equilibrium constant for dissociation of hydrogen molecules. The kinetics of the rate of conversion of ethane to ethylene in this system has been studied over the temperature range 876–1016 K. The results show that the rate-controlling step is[Formula: see text]and the value obtained for the rate constant is[Formula: see text](R = 1.987 cal mol−1 deg−1). This value is compared with values obtained from other methods over the temperature range 300–1400 K. Combination with a recent measurement of the rate constant for the reverse reaction yields an experimental value for the equilibrium constant for the reaction.

scholarly journals REACTION KINETICS OF Cu ELECTRO-DEPOSITION ON THE SURFACE OF TiO2/GRAPHITE

2015 ◽  
Vol 8 (2) ◽  
pp. 116
Author(s):  
Fitria Rahmawati ◽  
Wanodya Anggit Mawasthi ◽  
Patiha
Keyword(s):  
Equilibrium Constant ◽  
Rate Constant ◽  
Reaction Rate ◽  
Reaction Order ◽  
Electrode Reaction ◽  
Deposition Process ◽  
Anodic Reaction ◽  
Electro Deposition ◽  
First Order ◽  
Kinetics Of

Research on the kinetics of electrode reaction during copper electro-deposition on the surface of TiO2/graphite has been conducted. The aims of this research are to determine the ratio of anodic reaction rate to cathodic reaction rate , the ratio of anodic rate constant to cathodic rate constant , the equilibrium constant when the reaction reach equilibrium condition and to study the polarization in the electro-deposition reaction. Copper was deposited electrochemically from CuSO4 solution at various concentration i.e. 0.1 M; 0.2 M; 0.3 M; 0.4 M; 0.5 M. In every 5 minutes during electro-deposition process, the pH changes in anode cell was recorded and the change of Cu2+ concentration was also analyzed by spectrophotometric method. The result shows that the reaction order of Cu2+ reduction is first order and the oxidation of H2O in anodic cell is zero order. The ratio of anodic rate constant to cathodic rate constant, is 4.589´10-3 ± 0.071´10‑3. It indicates that the reaction rate  in cathode is larger than the reaction rate in anode and it allowed polarization.  The electrochemical cell reached equilibrium after 25 minutes with the equilibrium constant is 8.188´10-10 ± 1.628´10-10.

Sign in / Sign up

Export Citation Format

Share Document